Total Payments
$1,157
2019 Payments
$116.42
Companies
12
Transactions
70
Payment Breakdown by Category
Food & Beverage$1,143 (98.7%)
Education$14.54 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,143 | 68 | 98.7% |
| Education | $14.54 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $266.82 | 9 | $0 (2019) |
| UCB, Inc. | $257.21 | 18 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $222.29 | 14 | $0 (2017) |
| Biogen, Inc. | $104.02 | 11 | $0 (2017) |
| Supernus Pharmaceuticals, Inc. | $95.78 | 6 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $48.31 | 3 | $0 (2019) |
| EMD Serono, Inc. | $39.94 | 2 | $0 (2018) |
| ACADIA Pharmaceuticals Inc | $38.09 | 2 | $0 (2017) |
| PFIZER INC. | $36.38 | 2 | $0 (2018) |
| GE Healthcare | $18.24 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $116.42 | 2 | GENZYME CORPORATION ($100.00) |
| 2018 | $265.36 | 14 | GENZYME CORPORATION ($67.11) |
| 2017 | $775.26 | 54 | Sunovion Pharmaceuticals Inc. ($222.29) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/30/2019 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 04/16/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2018 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $14.73 | General |
| Category: AED | ||||||
| 10/12/2018 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $19.00 | General |
| Category: AED | ||||||
| 09/11/2018 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $16.09 | General |
| Category: AED | ||||||
| 08/07/2018 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Neurology | ||||||
| 08/01/2018 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $16.79 | General |
| Category: AED | ||||||
| 06/20/2018 | UCB, Inc. | Vimpat (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Neurology | ||||||
| 06/13/2018 | EMD Serono, Inc. | Rebif (Biological) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Neurology | ||||||
| 05/23/2018 | GENZYME CORPORATION | LEMTRADA (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 04/11/2018 | GENZYME CORPORATION | LEMTRADA (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 03/21/2018 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $35.68 | General |
| Category: Neurology | ||||||
| 03/11/2018 | GE Healthcare | — | Food and Beverage | Cash or cash equivalent | $18.24 | General |
| 03/06/2018 | GENZYME CORPORATION | LEMTRADA (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 02/14/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.09 | General |
| 01/24/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 12/20/2017 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Neurology | ||||||
| 12/07/2017 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA, ZINBRYTA | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: NEUROLOGY | ||||||
| 11/28/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 11/20/2017 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA, ZINBRYTA | Food and Beverage | In-kind items and services | $7.14 | General |
| Category: NEUROLOGY | ||||||
| 11/06/2017 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $117.64 | General |
| Category: CNS | ||||||
| 10/25/2017 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: PDP | ||||||
| 10/04/2017 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Neurology | ||||||
| 10/03/2017 | PFIZER INC. | LYRICA (Drug), EMBEDA | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 09/27/2017 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Neurology | ||||||
About Dr. Danny Watson, MD
Dr. Danny Watson, MD is a Neurology healthcare provider based in Bloomfield Township, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1831189299.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danny Watson, MD has received a total of $1,157 in payments from pharmaceutical and medical device companies, with $116.42 received in 2019. These payments were reported across 70 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,143).
Ad
Practice Information
- Specialty Neurology
- Location Bloomfield Township, MI
- Active Since 10/26/2005
- Last Updated 10/18/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831189299
Products in Payments
- Briviact (Drug) $223.80
- APTIOM (Drug) $222.29
- AUBAGIO (Drug) $168.15
- LEMTRADA (Drug) $98.67
- TYSABRI (Biological) $89.48
- TROKENDI XR (Drug) $67.99
- Rebif (Biological) $39.94
- NUPLAZID (Drug) $38.09
- LYRICA (Drug) $36.38
- OXTELLAR XR (Drug) $27.79
- Neupro (Drug) $19.93
- VRAYLAR (Drug) $17.19
- AIMOVIG (Biological) $16.42
- GILENYA (Drug) $14.80
- TECFIDERA (Drug) $14.54
- Vimpat (Drug) $13.48
- Fycompa (Drug) $12.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.